Exact Sciences [EXAS] vs Charles River [CRL] Detailed Stock Comparison
Exact Sciences
NASDAQ
Loading...
Charles River
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Exact Sciences wins in 4 metrics, Charles River wins in 15 metrics, with 0 ties. Charles River appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Exact Sciences | Charles River | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -8.17 | 681.33 | Exact Sciences |
| Price-to-Book Ratio | 3.46 | 2.30 | Charles River |
| Debt-to-Equity Ratio | 102.73 | 82.04 | Charles River |
| PEG Ratio | 0.09 | -17.28 | Charles River |
| EV/EBITDA | 130.49 | 10.84 | Charles River |
| Profit Margin (TTM) | -34.19% | -1.66% | Charles River |
| Operating Margin (TTM) | 0.34% | 16.67% | Charles River |
| EBITDA Margin (TTM) | 0.34% | 16.67% | Charles River |
| Return on Equity | -35.51% | -1.81% | Charles River |
| Return on Assets (TTM) | -1.39% | 4.31% | Charles River |
| Free Cash Flow (TTM) | $74.55M | $501.61M | Charles River |
| 1-Year Return | -20.49% | -21.16% | Exact Sciences |
| Price-to-Sales Ratio (TTM) | 2.90 | 1.91 | Charles River |
| Enterprise Value | $10.21B | $10.36B | Charles River |
| EV/Revenue Ratio | 3.47 | 2.57 | Charles River |
| Gross Profit Margin (TTM) | 69.35% | 34.59% | Exact Sciences |
| Revenue per Share (TTM) | $16 | $80 | Charles River |
| Earnings per Share (Diluted) | $-5.45 | $-1.30 | Charles River |
| Beta (Stock Volatility) | 0.93 | 1.48 | Exact Sciences |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Exact Sciences vs Charles River Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Exact Sciences | 1.69% | 4.10% | -4.74% | -15.95% | -7.43% | -16.62% |
| Charles River | 4.72% | 3.29% | -0.93% | 19.35% | -5.08% | -11.39% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Exact Sciences | -20.49% | 28.61% | -35.11% | 112.49% | 952.55% | 1,798.80% |
| Charles River | -21.16% | -20.98% | -25.58% | 129.95% | 455.96% | 217.40% |
Performance & Financial Health Analysis: Exact Sciences vs Charles River
| Metric | EXAS | CRL |
|---|---|---|
| Market Information | ||
| Market Cap | $8.54B | $7.71B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 5,478,610 | 1,229,490 |
| 90 Day Avg. Volume | 3,400,480 | 959,357 |
| Last Close | $47.47 | $161.84 |
| 52 Week Range | $38.81 - $72.83 | $91.86 - $230.02 |
| % from 52W High | -34.82% | -29.64% |
| All-Time High | $159.54 (Jan 25, 2021) | $460.21 (Sep 20, 2021) |
| % from All-Time High | -70.25% | -64.83% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.16% | 0.01% |
| Quarterly Earnings Growth | 0.16% | -0.44% |
| Financial Health | ||
| Profit Margin (TTM) | -0.34% | -0.02% |
| Operating Margin (TTM) | 0.00% | 0.17% |
| Return on Equity (TTM) | -0.36% | -0.02% |
| Debt to Equity (MRQ) | 102.73 | 82.04 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $13.05 | $68.14 |
| Cash per Share (MRQ) | $4.53 | $3.72 |
| Operating Cash Flow (TTM) | $305.61M | $787.45M |
| Levered Free Cash Flow (TTM) | $140.26M | $706.38M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | $0.00 |
Valuation & Enterprise Metrics Analysis: Exact Sciences vs Charles River
| Metric | EXAS | CRL |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -8.17 | 681.33 |
| Forward P/E | -132.62 | 15.24 |
| PEG Ratio | 0.09 | -17.28 |
| Price to Sales (TTM) | 2.90 | 1.91 |
| Price to Book (MRQ) | 3.46 | 2.30 |
| Market Capitalization | ||
| Market Capitalization | $8.54B | $7.71B |
| Enterprise Value | $10.21B | $10.36B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 3.47 | 2.57 |
| Enterprise to EBITDA | 130.49 | 10.84 |
| Risk & Other Metrics | ||
| Beta | 0.93 | 1.48 |
| Book Value per Share (MRQ) | $13.05 | $68.14 |
Financial Statements Comparison: Exact Sciences vs Charles River
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | EXAS | CRL |
|---|---|---|
| Revenue/Sales | $706.79M | $984.17M |
| Cost of Goods Sold | $206.24M | $666.44M |
| Gross Profit | $500.55M | $317.73M |
| Research & Development | $105.31M | N/A |
| Operating Income (EBIT) | $-89.76M | $74.67M |
| EBITDA | $-36.86M | $184.23M |
| Pre-Tax Income | $-100.99M | $35.98M |
| Income Tax | $224,000 | $10.10M |
| Net Income (Profit) | $-101.22M | $25.88M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | EXAS | CRL |
|---|---|---|
| Cash & Equivalents | $347.13M | $229.36M |
| Total Current Assets | $1.37B | $1.51B |
| Total Current Liabilities | $502.47M | $1.05B |
| Long-Term Debt | $2.49B | $2.99B |
| Total Shareholders Equity | $2.40B | $3.24B |
| Retained Earnings | $-4.60B | $1.84B |
| Property, Plant & Equipment | $126.66M | $402.91M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | EXAS | CRL |
|---|---|---|
| Operating Cash Flow | $-36.98M | $130.09M |
| Capital Expenditures | $-31.17M | N/A |
| Free Cash Flow | $-365,000 | $112.37M |
| Debt Repayment | $-249.17M | $-149.39M |
| Common Stock Repurchase | N/A | $-353.13M |
Short Interest & Institutional Ownership Analysis
| Metric | EXAS | CRL |
|---|---|---|
| Shares Short | 6.88M | 2.19M |
| Short Ratio | 3.00 | 2.73 |
| Short % of Float | 0.04% | 0.05% |
| Average Daily Volume (10 Day) | 5,478,610 | 1,229,490 |
| Average Daily Volume (90 Day) | 3,400,480 | 959,357 |
| Shares Outstanding | 185.62M | 51.14M |
| Float Shares | 187.46M | 48.62M |
| % Held by Insiders | 0.01% | 0.01% |
| % Held by Institutions | 0.96% | 1.13% |
Dividend Analysis & Yield Comparison: Exact Sciences vs Charles River
| Metric | EXAS | CRL |
|---|---|---|
| Last 12-Month Dividend | N/A | $0.00 |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | $0.00 |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | $0.00 |
| Ex-Dividend Date | N/A | N/A |